Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

Nonalcoholic fatty liver disease (NAFLD) is a group of obesity-associated pathological changes characterized by abnormal accumulation of lipids in cells of the liver parenchyma. NAFLD and associated conditions, namely insulin resistance and type II diabetes mellitus (DM2), as well as the possible ri...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Сахарный диабет
المؤلفون الرئيسيون: Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Endocrinology Research Centre 2017-12-01
الموضوعات:
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
farnesoid x
الوصول للمادة أونلاين:https://www.dia-endojournals.ru/jour/article/view/9374

الانترنت

https://www.dia-endojournals.ru/jour/article/view/9374

مواد مشابهة